X

Drug Profile

Benzyl aminolevulinate

Alternative Names: 5-ALA benzylester; 5-ALA benzylesther; Benzvix

Latest Information Update: 15 Nov 2006

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator PhotoCure
Class Antineoplastics; Oxidants
Mechanism of Action Photosensitisers

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued Gastrointestinal cancer

Most Recent Events

15 Nov 2006 Discontinued - Preclinical for Gastrointestinal cancer in Europe (Topical)
21 Apr 2005 Preclinical trials in Gastrointestinal cancer in Europe (Topical)
14 May 2002 Clinical pilot trials in premalignant lesions of the gastrointestinal tract in Europe (Topical)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com